Vioxx News

 

Merck To Start Issuing Checks In Vioxx Settlement

-courant.com

07/19/2008- Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits.

The decision marks the beginning of the end of the four-year legal saga, which began when cardiovascular side effects forced Merck to pull Vioxx off the market in 2004, triggering tens of thousands of lawsuits, sullying its once-spotless reputation and forcing out its chief executive.

The Vioxx case has cost Merck at least $6.8 billion, including more than $1.53 billion through March 31 on legal costs for defense research and individual trials, most of which it has won.

Vioxx, which was launched in 1999, brought Merck revenue of $2.5 billion at its peak in 2003 and a total of at least $11 billion.

On Thursday, Whitehouse Station, N.J.-based Merck said more than 97 percent of eligible claimants — 48,550 out of 49,960 — have enrolled in the settlement program, surpassing threshold levels the company required for the deal to proceed. Therefore, Merck said that on Aug. 4 it will waive its right to walk away from the deal reached with plaintiffs' attorneys last fall.

If you or a loved one have experienced side effects from taking Vioxx, you may be entitled to compensation. Call the Vioxx attorneys at Ennis & Ennis P.A. or fill out the form on this page for a free case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have about Vioxx side effects, Vioxx lawsuits, or any other Vioxx litigation.